Published in Blood Weekly, August 28th, 2003
Total revenues for the second quarter of 2003 were $50.7 million compared to $34.9 million for the second quarter of 2002, an increase of 45%.
Product sales for the second quarter of 2003 were $46.3 million, compared to $29.8 million for the second quarter of 2002, an increase of 55%. Net income for the second quarter was $8.1 million, or $0.34 per diluted share, compared to net income of $550,000, or $0.02 per diluted share, in the second quarter of 2002.
For the first 6 months of 2003, the company's revenues were $96.9...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.